Date
2022-03-31Journal
Nature MedicinePublisher
Springer NatureType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/18570ae974a485f413a2113503eed53cd6c53
10.1038/s41591-022-01778-3
Scopus Count
Related articles
- Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
- Authors: Tostanoski LH, Gralinski LE, Martinez DR, Schaefer A, Mahrokhian SH, Li Z, Nampanya F, Wan H, Yu J, Chang A, Liu J, McMahan K, Ventura JD, Dinnon KH, Leist SR, Baric RS, Barouch DH
- Issue date: 2021 Nov 9
- Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development.
- Authors: Nguyen LC, Bakerlee CW, McKelvey TG, Rose SM, Norman AJ, Joseph N, Manheim D, McLaren MR, Jiang S, Barnes CF, Kinniment M, Foster D, Darton TC, Morrison J
- Issue date: 2021 Feb 16
- SARS-CoV-2: International Investigation Under the WHO or BWC.
- Authors: Himmel M, Frey S
- Issue date: 2021
- Experimental Models of COVID-19.
- Authors: Caldera-Crespo LA, Paidas MJ, Roy S, Schulman CI, Kenyon NS, Daunert S, Jayakumar AR
- Issue date: 2021
- COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.
- Authors: Conforti A, Marra E, Palombo F, Roscilli G, Ravà M, Fumagalli V, Muzi A, Maffei M, Luberto L, Lione L, Salvatori E, Compagnone M, Pinto E, Pavoni E, Bucci F, Vitagliano G, Stoppoloni D, Pacello ML, Cappelletti M, Ferrara FF, D'Acunto E, Chiarini V, Arriga R, Nyska A, Di Lucia P, Marotta D, Bono E, Giustini L, Sala E, Perucchini C, Paterson J, Ryan KA, Challis AR, Matusali G, Colavita F, Caselli G, Criscuolo E, Clementi N, Mancini N, Groß R, Seidel A, Wettstein L, Münch J, Donnici L, Conti M, De Francesco R, Kuka M, Ciliberto G, Castilletti C, Capobianchi MR, Ippolito G, Guidotti LG, Rovati L, Iannacone M, Aurisicchio L
- Issue date: 2022 Jan 5